Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
Vectors used in gene therapy for hemoglobin disorders carry globin in a reverse-orientation to prevent the loss of key regulatory elements by RNA splicing, but this limits their efficiency. Here, the authors develop a vector carrying β-globin in a forward orientation and show that it has improved ti...
Main Authors: | Naoya Uchida, Matthew M. Hsieh, Lydia Raines, Juan J. Haro-Mora, Selami Demirci, Aylin C. Bonifacino, Allen E. Krouse, Mark E. Metzger, Robert E. Donahue, John F. Tisdale |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-12456-3 |
Similar Items
-
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number
by: Naoya Uchida, et al.
Published: (2013-01-01) -
Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production
by: Naoya Uchida, et al.
Published: (2018-06-01) -
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
by: Naoya Uchida, et al.
Published: (2021-06-01) -
Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus stem cell gene therapy model
by: Naoya Uchida, et al.
Published: (2016-01-01) -
High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2
by: Naoya Uchida, et al.
Published: (2019-06-01)